Linda Grais Net Worth

The estimated Net Worth of Linda Grais is at least $1.88 Million dollars as of 15 May 2023. Linda Grais owns over 10,000 units of PRA Health Sciences Inc stock worth over $1,652,100 and over the last 16 years he sold PRAH stock worth over $0. In addition, he makes $227,500 as Independent Director at PRA Health Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Linda Grais PRAH stock SEC Form 4 insiders trading

Linda has made over 5 trades of the PRA Health Sciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of PRAH stock worth $24,500 on 15 May 2023.

The largest trade he's ever made was buying 10,000 units of PRA Health Sciences Inc stock on 15 May 2023 worth over $24,500. On average, Linda trades about 833 units every 56 days since 2009. As of 15 May 2023 he still owns at least 10,000 units of PRA Health Sciences Inc stock.

You can see the complete history of Linda Grais stock trades at the bottom of the page.

Linda Grais biography

Dr. Linda S. Grais M.D. serves as Independent Director of the Company. Dr. Grais served as a member of the board of directors of Ocera Therapeutics, Inc. from January 2008 through December 2017 and as President and Chief Executive Officer of Ocera Therapeutics, Inc., a biopharmaceutical company, from June 2012 to December 2017. Prior to her employment by Ocera Therapeutics, Dr. Grais served as a managing member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company focusing on new treatments for cancer. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich & Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. She currently serves on the boards of directors of Corvus Pharmaceuticals, Inc., Zosano Pharma Company and Arca Biopharma, Inc. and sits on the audit committees of Corvus Pharmaceuticals, Inc., Zosano Pharma Company and Arca Biopharma, Inc. and on the compensation committee of Arca Biopharma, Inc. Dr. Grais received a B.A. from Yale University, an M.D. from Yale Medical School and a J.D. from Stanford Law School.

What is the salary of Linda Grais?

As the Independent Director of PRA Health Sciences Inc, the total compensation of Linda Grais at PRA Health Sciences Inc is $227,500. There are 3 executives at PRA Health Sciences Inc getting paid more, with Colin Shannon having the highest compensation of $7,160,220.

How old is Linda Grais?

Linda Grais is 63, he's been the Independent Director of PRA Health Sciences Inc since 2015. There are 1 older and 9 younger executives at PRA Health Sciences Inc. The oldest executive at PRA Health Sciences Inc is Jeffrey Barber, 67, who is the Independent Director.

What's Linda Grais's mailing address?

Linda's mailing address filed with the SEC is 4130 Parklake Ave # 400, Raleigh, NC 27612, USA.

Insiders trading at PRA Health Sciences Inc

Over the last 10 years, insiders at PRA Health Sciences Inc have traded over $5,843,308,181 worth of PRA Health Sciences Inc stock. The most active insiders traders include Fund Holdings L.P.Kkr Fund ..., Fund Holdings L.P.Kkr Fund ..., and Pra Investors L.P.Kkr Pra I.... On average, PRA Health Sciences Inc executives and independent directors trade stock every 39 days with the average trade being worth of $280,602,577. The most recent stock trade was executed by Christopher L Gaenzle on 17 June 2021, trading 27,497 units of PRAH stock currently worth $2,773,897.

What does PRA Health Sciences Inc do?

PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.

Complete history of Linda Grais stock trades at ARCA biopharma Inc, Corvus Pharmaceuticals Inc, PRA Health Sciences Inc, and Zosano Pharma Corp

PRA Health Sciences Inc executives and stock owners

PRA Health Sciences Inc executives and other stock owners filed with the SEC include:

• Colin Shannon,
  Chairman of the Board, President, Chief Executive Officer
• Michael Bonello,
  Chief Financial Officer, Executive Vice President
• Colin Shannon,
  Chairman, CEO & Pres
• Linda Grais,
  Independent Director
• Jeffrey Barber,
  Independent Director
• Matthew Young,
  Independent Director
• Alexander Dickinson,
  Independent Director
• James Momtazee,
  Lead Independent Director
• Glen Stettin,
  Independent Director
• Christopher Gaenzle,
  Executive Vice President, Chief Administrative Officer, General Counsel
• Dr. Michael Kirchengast,
  Sr. VP of Scientific Affairs
• Patrick R. Spine,
  VP of HR
• Tami Klerr-Naivar,
  Exec. VP and Chief Sales & Marketing Officer
• Laurie Hurst,
  Sr. Director of Communications & PR
• Thomas Byrne,
  VP of Legal Affairs
• Kent Thoelke,
  Exec. VP & Chief Scientific Officer
• Margaret Keegan,
  Exec. VP & COO
• Pra Investors L.P.Kkr Pra I...,
  
• Fund Holdings L.P.Kkr Fund ...,
  
• Fund Holdings L.P.Kkr Fund ...,
  
• David W Dockhorn,
  Executive VP & CCO
• Linda Baddour,
  Executive VP & CFO
• Pra Investors L.P.Kkr Pra I...,
  
• Group Ltd Kkr Group Holding...,
  
• Fund Holdings L.P.Kkr Fund ...,